A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.

Peptides delivered on the surface of influenza virosomes have been shown to induce solid humoral immune responses in experimental animals. High titers of peptide-specific antibodies were also induced in a phase 1a clinical trial in volunteers immunized with virosomal formulations of two peptides der...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shinji L Okitsu, Olivier Silvie, Nicole Westerfeld, Marija Curcic, Andreas R Kammer, Markus S Mueller, Robert W Sauerwein, John A Robinson, Blaise Genton, Dominique Mazier, Rinaldo Zurbriggen, Gerd Pluschke
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2007-12-01
coleção:	PLoS ONE
Acesso em linha:	http://europepmc.org/articles/PMC2093993?pdf=render
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!